Detalhe da pesquisa
1.
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
Circulation
; 149(4): 279-289, 2024 01 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37634130
2.
Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-ß2-glycoprotein I antibody titers.
Res Pract Thromb Haemost
; 7(1): 100011, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36891523
3.
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.
BMJ Open
; 9(12): e032488, 2019 12 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31888928